Abstract:Background: Oritavancin is a new generation of semi-synthetic glycopeptide antibiotics against Gram-positive bacteria, which served as the first and only antibiotic with a single-dose therapeutic regimen to treat ABSSSI. A naturally occurring glycopeptide A82846B is the direct precursor of oritavancin. However, its application has been hampered by low yields and homologous impurities. This study established a multi-step combinatorial strategy to rationally construct a high-quality and high-efficiency biosynthesis system for A82846B and systematically optimize its fermentation process to break through the bottleneck of microbial fermentation production. Results: Firstly, based on the genome sequencing and analysis, we deleted putative competitive pathways and constructed a better A82846B-producing strain with a cleaner metabolic background, increasing A82846B production from 92 to 174 mg/L. Subsequently, the PhiC31 integrase system was introduced based on the CRISPR-Cas12a system. Then, the fermentation level of A82846B was improved to 226 mg/L by over-expressing the pathway-specific regulator StrR via the constructed PhiC31 system. Furthermore, overexpressing glycosyl-synthesis gene evaE enhanced the production to 332 mg/L due to the great conversion of the intermediate to target product. Finally, the scale-up production of A82846B reached 725 mg/L in a 15 L fermenter under fermentation optimization, which is the highest reported yield of A82846B without the generation of homologous impurities. Conclusion: Under approaches including blocking competitive pathways, inserting site-specific recombination system, overexpressing regulator, overexpressing glycosyl-synthesis gene and optimizing fermentation process, a multi-step combinatorial strategy for the high-level production of A82846B was developed, constructing a high-producing strain AO-6. The combinatorial strategies employed here can be widely applied to improve the fermentation level of other microbial secondary metabolites, providing a reference for constructing an efficient microbial cell factory for high-value natural products.

Enhanced Production Of Validamycin A By H2o2-Induced Reactive Oxygen Species In Fermentation Of Streptomyces Hygroscopicus 5008

Enhancement of validamycin A production by addition of ethanol in fermentation of Streptomyces hygroscopicus 5008.

Alkaline Ph Shock Enhanced Production of Validamycin A in Fermentation of Streptomyces Hygroscopicus.

Significance of Oxygen Carriers and Role of Liquid Paraffin in Improving Validamycin A Production

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Alleviation of the Byproducts Formation Enables Highly Efficient Biosynthesis of Rosmarinic Acid in Saccharomyces cerevisiae

Enhanced Poly(γ‐glutamic Acid) Production by H2O2‐induced Reactive Oxygen Species in the Fermentation of Bacillus Subtilis NX‐2

Novel Spectrophotometric Approach for Determination of Validamycin A in Fermentation of Streptomyces Hygroscopicus

Effects of Amino Acids on the Biosynthesis of Validamycin A in the Fermentation of Streptomyces Hygroscopicus 5008

Metabolic engineering of Escherichia coli for de novo production of 5-hydroxyvalerate via L-lysine α-oxidase pathway

Improvement of violacein production using abiotic stresses and microbial adaptation

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Improving the Yield and Quality of Daptomycin in Streptomyces Roseosporus by Multilevel Metabolic Engineering

Metabolic engineering of Escherichia coli for the efficient production of 5-hydroxyvaleric acid

Avilamycin production enhancement by mutagenesis and fermentation optimization in Streptomyces viridochromogenes

Enhancing Oleanolic Acid Production in Engineered Saccharomyces Cerevisiae

Rapid Contamination Detection in Validamycin A Production by HS-SPME/GC-MS

Industrial Production of Antibiotics in Fungi: Current State, Deciphering the Molecular Basis of Classical Strain Improvement and Increasing the Production of High-Yielding Strains by the Addition of Low-Molecular Weight Inducers

Production improvement of an antioxidant in cariogenic Streptococcus mutans UA140

Stepwise engineering of Saccharomyces cerevisiae to produce (+)-valencene and its related sesquiterpenes

Metabolic Engineering of Corynebacterium glutamicum for the High-Level Production of l-Valine under Aerobic Conditions